Skip to main content
Signal8

ZEVRA THERAPEUTICS, INC. (ZVRA)

Zevra Therapeutics, Inc., founded in 2006 and based in Celebration, Florida, is a biopharmaceutical company dedicated to discovering and developing innovative treatments for rare diseases. The company employs its proprietary Ligand Activated Therapy (LAT) technology to create novel prodrug versions of existing FDA-approved medications or to enable new applications for other compounds, primarily addressing serious medical conditions within the United States. Zevra's development pipeline is strategically concentrated on high-unmet-need therapeutic areas, including attention deficit hyperactivity disorder (ADHD), stimulant use disorder, and various rare central nervous system (CNS) conditions, such as idiopathic hypersomnia (IH). Their lead product candidate, KP1077, which is a prodrug of d-methylphenidate (known as serdexmethylphenidate), is currently in Phase II clinical trials for the treatment of both IH and narcolepsy. Another key prodrug candidate, KP879, is also advancing through Phase II studies for stimulant use disorder. In addition to its pipeline, Zevra has successfully secured FDA approval for two products: AZSTARYS, a once-daily treatment for ADHD in patients aged six years and older, and APADAZ, an immediate-release combination product containing benzhydrocodone (a prodrug of hydrocodone) and acetaminophen. The company's product portfolio also includes arimoclomol, and it holds collaboration and licensing agreements with KVK-Tech, Inc. and Commave Therapeutics SA. Formerly known as KemPharm, Inc., the company officially rebranded to Zevra Therapeutics, Inc. in February 2023.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Zevra Therapeutics, Inc. logo

Zevra Therapeutics, Inc.

NASDAQ:ZVRAHealthcare
-0.77%$10.28
AH$10.28+0.00%vs close
Mkt Cap$610.47M
Float57.6M
O/S59.38M
Vol
$ Vol
RVOL
Inst Own78.1%
SI10.8%
Earnings
Dilution
Financials Summary
Revenue$106.47M
Net Income$83.23M
Total Assets$284.73M
Free Cash Flow-$2.43M
Debt & Equity
Debt 29%
Equity 71%
Total Debt$63.21M
Total Equity$154.66M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in ZVRA's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$284.73M
Liabilities$130.07M
Accounts Receivable$23.26M
Accounts Payable$2.48M
Inventory$1.74M
PP&E (Net)$1.7M
Goodwill$4.7M
Intangible Assets$6.42M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$106.47M$23.61M$27.46M$10.16M$28.65M$13.29M$12.84M$0$0$0$0$0$0$0
YoY Growth350.9%-14.0%170.3%-64.5%115.6%3.5%--------
Cost of Revenue$16.48M$7.42M$2.94M$222K$2.06M$1.3M$2.94M$324K$336K$175K$84K$0$0$0
Gross Profit$89.99M$16.2M$24.52M$9.94M$26.59M$11.98M$9.89M-$324K-$336K-$175K-$84K$0$0$0
Gross Margin84.5%68.6%89.3%97.8%92.8%90.2%77.1%-------
Research and Development$12.74M$42.09M$39.81M$19.8M$10.16M$8.84M$19.41M$41.76M$20.59M$20.47M$13.93M$11.92M$3.37M$2.99M
Selling, General, and Administrative$77.62M$54.87M$35.09M$15.04M$8.7M$7.92M$10.82M$12.51M$12.77M$14M$8.88M$4.53M$1.35M$2.34M
Other$3.86M$6.24M-$775K$17.66M$0$828K$0$0$0$0$0$0$0$0
Total Operating Expenses$94.22M$103.2M$74.12M$52.5M$18.86M$17.59M$30.23M$54.27M$33.37M$34.47M$22.81M$16.44M$4.72M$142K
Operating Income (EBIT)-$4.23M-$87M-$49.6M-$42.56M$7.73M-$5.61M-$20.34M-$55.9M-$33.37M-$37.48M-$22.81M-$16.44M-$4.72M-$5.34M
Operating Margin-4.0%-368.5%-180.6%-418.9%27.0%-42.2%-158.4%-------
Interest Expense$7.98M$7.35M$1.5M$335K$376K$7.09M$6.51M$7.09M$7.34M$7.13M$2.67M$2.72M$157K$0
Interest Income$6.95M$2.17M$4.54M$1.51M$261K$89K$309K$420K$365K$353K$32K$4K$52K$35K
Other Income (Expense)$90.91M-$3.14M$3.56M$15.76M-$16.25M-$7.18M-$4.21M-$689K-$10.06M$20.95M-$31.82M-$8.03M-$528K$5.23M
Income Before Tax (EBT)$86.68M-$90.14M-$46.05M-$26.8M-$8.52M-$12.79M-$24.54M-$56.59M-$43.43M-$16.53M-$54.64M-$24.48M-$5.25M-$108K
Income Tax Expense$3.45M$15.37M$0-$33K$34K-$34K-$22K-$126K-$43K-$15K$26K-$22K-$20K-$37K
Net Income$83.23M-$105.51M-$46.05M-$26.77M-$8.55M-$12.76M-$24.52M-$56.47M-$43.39M-$16.52M-$54.66M-$24.45M-$5.23M-$70K
Net Income Margin78.2%-446.9%-167.7%-263.5%-29.9%-96.0%-191.0%-------
Supplementary Data
EPS1.40-2.28-1.30-0.78-2.11-3.21-13.23-50.39-47.37-18.10-118.69-31.79-10.69-0.47
Diluted EPS1.35-2.28-1.30-0.78-2.11-3.21-13.23-50.39-47.37-18.10-118.69-31.79-10.69-0.47
Weighted Average OS55.31M46.25M35.45M34.49M29.77M3.98M1.85M1.12M915,806912,315460,542769,239488,959148,700
EBITDA$98.71M-$76.4M-$43.54M-$25.53M-$7.89M-$5.43M-$17.73M-$53.94M-$33.03M-$34.3M-$22.73M-$16.37M-$4.65M-$37K
EBITDA Margin92.7%-323.6%-158.6%-251.2%-27.5%-40.9%-138.1%-------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$62.41M$33.78M$43.05M$65.47M$112.35M$4.21M$3.22M$18.41M$10.87M$16.76M$32.32M$10.26M$1.97M$2.54M
Short-Term Investments$128.6M$35.71M$24.69M$17.38M$0$0$0$3.26M$31.36M$51M$19M$0$0$0
Cash and Short-Term Investments$191.01M$69.5M$67.74M$82.85M$112.35M$4.21M$3.22M$21.67M$42.23M$67.77M$51.32M$10.26M$1.97M$2.54M
Accounts Receivable$23.26M$10.51M$17.38M$8.3M$1.53M$2.58M$1.86M$140K$2.08M$5.06M$2.38M$22K$20K$28K
Inventory$1.74M$1.97M$24.08M$0$0$0$0$0$0$1.1M$0$0$0$0
Other Current Assets$7M$3.02M-$23.43M$1.11M$252K$312K$1.37M$0$1.38M$58K$0-$23K$51K$34K
Total Current Assets$223.01M$86.03M$86.94M$92.83M$115.06M$8.38M$6.97M$23.72M$45.9M$74.36M$54.08M$10.28M$2.04M$2.61M
Long-Term Assets
Property, Plant & Equipment Net$1.7M$1.01M$1.53M$1.78M$2.02M$2.39M$3.01M$1.75M$2M$1.97M$403K$352K$380K$319K
Goodwill$4.7M$4.7M$4.7M$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$6.42M$68.99M$69.23M$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$47.88M$6.01M$0$20M$15.42M$0$0$0$3.25M$8.2M$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$1.02M$11.38M$9.94M$724K$438K$438K$527K$1.27M$1.31M$360K$1.24M$3.08M$9K$0
Total Long-Term Assets$61.72M$92.1M$85.39M$22.51M$17.89M$2.83M$3.54M$3.02M$6.56M$10.53M$1.65M$3.44M$389K$319K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$4K
Total Assets$284.73M$178.13M$172.33M$115.34M$132.94M$11.21M$10.51M$26.75M$52.46M$84.89M$55.72M$13.71M$2.43M$2.93M
Liabilities
Current Liabilities
Accounts Payable$2.48M$13.07M$13.99M$3.61M$516K$1.17M$1.14M$3.71M$2.18M$469K$1.25M$1.58M$386K$0
Short-Term Debt$0$0$37.7M$4.66M$0$390K$0$3.33M$3.33M$0$3.41M$807K$3.85M$47K
Current Income Tax Payable$13.71M$14.43M$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$4.63M$5.7M$0$0$0$0$0
Other Current Liabilities$22.67M$3.2M$10.82M$719K$821K$0$236K-$4.51M-$5.59M$41K$0-$438$0$1M
Total Current Liabilities$39.28M$34.06M$73.72M$12.02M$4.23M$7.54M$5.43M$12M$11.51M$6.64M$8.34M$3.93M$5.24M$1.13M
Long-Term Liabilities
Long-Term Debt$61.93M$59.5M$5.07M$12.8M$0$68.05M$77.34M$78.11M$89.4M$91.17M$19.66M$18.09M$35K$39K
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$28.01M$44.52M$31.22M$14.55M$355K$427K$288K$2.81M$8.5M$5.11M$37.84M$15.97M$21.36M$0
Total Long-Term Liabilities$90.8M$104.4M$36.74M$28.2M$1.59M$70.08M$79.53M$81.31M$98.46M$96.94M$57.5M$34.08M$21.45M$39K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$2.39M
Total Liabilities$130.07M$138.46M$110.46M$40.22M$5.82M$77.62M$84.96M$93.31M$109.97M$103.58M$65.84M$38.02M$26.7M$3.56M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$37.29M$18.95M$18.55M
Common Stock$6K$5K$4K$3K$4K$0$0$3K$1K$1K$1K$0$1.44M$1.3M
Retained Earnings-$422.06M-$505.29M-$399.78M-$353.73M-$267.03M-$258.47M-$245.71M-$221.19M-$164.73M-$121.34M-$104.82M-$50.16M-$25.71M-$20.48M
Comprehensive Income & Other-$764K$631K-$43K$113K-$0$0$0$0$0$0$0-$0-$20.39M$0
Other Stockholders' Equity$576.71M$544.95M$461.64M$428.85M$394.14M$192.06M$171.26M$154.62M$107.21M$102.64M$94.7M$25.86M$0$18.55M
Total Equity$154.66M$39.67M$61.86M$75.12M$127.12M-$66.41M-$74.46M-$66.57M-$57.52M-$18.7M-$10.12M-$24.3M-$24.27M-$627K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$284.73M$178.13M$172.33M$115.34M$132.94M$11.21M$10.51M$26.75M$52.46M$84.89M$55.72M$13.71M$2.43M$2.93M
Supplementary Data
Total Debt$63.21M$60.3M$43.77M$18.78M$1.61M$70.55M$79.53M$82.05M$93.48M$91.98M$23.1M$18.95M$3.97M$87K
Net Debt$800K$26.51M$716K-$46.69M-$110.74M$66.33M$76.31M$63.64M$82.61M$75.22M-$9.22M$8.7M$2M-$2.45M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income$83.23M-$105.51M-$46.05M-$26.77M-$8.55M-$12.76M-$24.52M-$56.47M-$43.39M-$16.52M-$54.66M-$24.45M-$5.23M-$70K
Depreciation & Amortization$4.05M$6.39M$1.01M$944K$257K$273K$304K$324K$336K$175K$84K$75K$68K$63K
Deferred Income Tax$3.45M$15.37M$0$0$16.2M$435K-$2M-$5.98M$164K$6.89M$1.91M-$789K$1.56M$0
Stock-Based Compensation$12.63M$14.91M$5.95M$0$2.44M$2.49M$4.41M$6.5M$4.56M$6.6M$2.37M$214K$134K$468K
Changes in Working Capital:
  Accounts Receivable-$11.98M$6.87M-$9.08M-$6.77M$1.05M-$714K-$1.73M$0$0$0$0$0$0$0
  Inventory-$1.3M-$8.87M$206K$147K$0$0$5.51M$0$0$0$0$0$0$0
  Accounts Payable-$15.59M-$3.6M$11.13M$3.13M-$1.11M$931K-$3.79M-$1.64M-$801K$1.12M$0$0$0$0
  Other Working Capital$2.36M-$1.04M$3.63M$3.09M-$295K$157K-$5.12M-$650K-$849K$3.32M$87K$523K-$4K$0
Total Working Capital Change-$26.51M-$6.64M$5.88M-$406K-$357K$374K-$5.12M-$2.29M-$1.65M$3.32M$87K$1.46M$122K$0
Other Non-Cash Items-$78.45M$5.82M-$329K$7.52M$460K$7.25M$3.19M$3.71M$6.87M-$30.24M$29.95M$8.82M-$985K-$4.89M
Net Cash from Operating-$1.6M-$69.67M-$33.53M-$18.72M$10.44M-$1.94M-$23.74M-$54.2M-$33.1M-$29.77M-$20.27M-$14.67M-$4.33M-$4.43M
Investing Activities
Capital Expenditures-$835K$0-$296K-$93K-$102K-$33K-$26K-$21K-$181K-$643K-$135K-$49K-$51K-$19K
Acquisitions$0$0-$30.4M-$14.09M$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$309.99M-$41.16M-$45.81M-$23.86M-$15.42M$0$0$0-$27.38M-$89.85M-$19M$0$0$0
Sales of Investments$328.5M$25M$59.12M$1.32M$0$0$3.26M$33.35M$54.97M$44.65M$0$0$0$0
Other Investing Activities$448K-$6M$0$0$0$0$0$33.35M$27.59M-$1.1M-$19M$5K$17K$5.07M
Net Cash from Investing$18.13M-$22.16M-$17.39M-$36.72M-$15.52M-$33K$3.23M$33.33M$27.41M-$46.95M-$19.14M-$44K-$34K$5.05M
Financing Activities
Debt Repaid--$16.29M-$24.89M-$12.78M$38.1M-$554K$207K$193K$157K-$62.17M-$3.97M-$24.97M-$3.79M$79K
Common Stock Issuance$12.44M$64.52M$6.32M$324K$49.28M-$84K$0$28.33M$4K-$842K$59.89M$0$0$525K
Common Stock Repurchases$0$0-$3.45M-$4.72M-$2.81M$0$0$0$0$0$0$0$0-$65K
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$372K$1.3M$692K-$33K$104.73M-$34K-$300K-$116K-$46K-$1.01M-$2.44M-$1.93M$0$0
Net Cash from Financing$12.06M$82.11M$28.46M$8.35M$113.11M$2.74M$4.94M$28.02M-$203K$61.16M$61.47M$23M$3.79M$381K
Forex Effect$28K$454K$44K$204K$0$0$0$0$0$0$0$0$0$1.55M
Net Change in Cash$28.62M-$9.26M-$22.42M-$46.88M$108.02M$767K-$15.56M$7.15M-$5.89M-$15.56M$22.06M$8.29M-$573K$2.54M
Supplementary Data
Operating Cash Flow-$1.6M-$69.67M-$33.53M-$18.72M$10.44M-$1.94M-$23.74M-$54.2M-$33.1M-$29.77M-$20.27M-$14.67M-$4.33M-$4.43M
Capital Expenditure-$835K$0-$296K-$93K-$102K-$33K-$26K-$21K-$181K-$643K-$135K-$49K-$51K-$19K
Free Cash Flow-$2.43M-$69.67M-$33.83M-$18.81M$10.34M-$1.97M-$23.76M-$54.22M-$33.28M-$30.41M-$20.4M-$14.72M-$4.38M-$4.45M
Cash at Beginning$33.78M$43.05M$65.47M$112.35M$4.32M$3.56M$19.12M$11.97M$17.86M$32.32M$10.26M$1.97M$2.54M$0
Cash at End$62.41M$33.78M$43.05M$65.47M$112.35M$4.32M$3.56M$19.12M$11.97M$16.76M$32.32M$10.26M$1.97M$2.54M